TELO

Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ: TELO · HEALTHCARE · BIOTECHNOLOGY

$1.29

+3.25% today

Updated 2026-06-04

Market cap

$86.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$86.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$15.50

+1101.55%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.77M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-854147.00	$-13.07M	$-16.53M	$-10.41M	$-990947.00
EPS	—	—	—	—	$-0.29
Free cash flow	$-468661.00	$-3.86M	$-5.07M	$-3.69M	$-1.77M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TELO	$86.66M	16	4.3	3.0	5.0	6.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Telomir Pharmaceuticals, Inc. Common Stock trades at $1.29. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Telomir Pharmaceuticals, Inc. Common Stock's stock price?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) trades at $1.29.

Is Telomir Pharmaceuticals, Inc. Common Stock overvalued?

Telomir Pharmaceuticals, Inc. Common Stock carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Telomir Pharmaceuticals, Inc. Common Stock (TELO)?

The 12-month analyst consensus target is $15.50, about 1101.6% above the current $1.29. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

telomirpharma.com

Quick metrics

P/S ratio—

ROE-185.89%

Beta-0.21

50D MA$1.31

200D MA$1.35

Shares out0.07B

Float0.04B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TELO vs LLY →TELO vs JNJ →TELO vs ABBV →Stock screener →